Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid
- 1 January 1979
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 32 (1), 229-231
- https://doi.org/10.1111/j.1471-4159.1979.tb04533.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- PLATELET AND PLASMA AMINE OXIDASE INHIBITION AND URINARY AMINE EXCRETION CHANGES DURING PHENELZINE TREATMENTJournal of Nervous & Mental Disease, 1977
- Dopamine is a monoamine oxidase B substrate in manNature, 1977
- Conjugated 3,4 dihydroxy phenyl acetic acid (DOPAC) in human and monkey cerebrospinal fluid and rat brain and the effects of probenecid treatmentLife Sciences, 1976
- Simultaneous assay by mass fragmentography of vanillyl mandelic acid, homovanillic acid, and 3-methoxy-4-hydroxy-phenethylene glycol in cerebrospinal fluid and urineBiochemical Medicine, 1974
- Derivatization and gas chromatographic determination of some biologically important acids in cerebrospinal fluidAnalytical Biochemistry, 1974
- Further studies on the inhibition of monoamine oxidase by M & B 9302 (clorgyline)—I: Substrate specificity in various mammalian speciesBiochemical Pharmacology, 1969
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968
- 5-HYDROXYINDOLE COMPOUNDS IN THE CEREBROSPINAL FLUID OF PATIENTS WITH PSYCHIATRIC OR NEUROLOGICAL DISEASESThe Lancet, 1966
- ANTIDEPRESSANT EFFECTS OF MAO INHIBITORS*Annals of the New York Academy of Sciences, 1963